Danaher acquires AB SCIEX and Molecular Devices

Reviewed

From DanaherFeb 1 2010

Danaher Corporation (NYSE: DHR) announced today that it has completed the previously announced acquisition of AB SCIEX and Molecular Devices. AB SCIEX is a leading designer and manufacturer of mass spectrometers, highly sensitive and sophisticated instruments used by researchers and clinicians to identify and quantify specific molecules in complex samples.

Molecular Devices supplies high-performance bio-analytical instrumentation systems and consumables that accelerate and improve research productivity and effectiveness in life science research and drug discovery.

Source:

Danaher Corporation

Posted in:

Tags: Drug Discovery, Life science, Research

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Danaher. (2019, June 18). Danaher acquires AB SCIEX and Molecular Devices. News-Medical. Retrieved on November 23, 2024 from https://www.news-medical.net/news/20100201/Danaher-acquires-AB-SCIEX-and-Molecular-Devices.aspx.
MLA
Danaher. "Danaher acquires AB SCIEX and Molecular Devices". News-Medical. 23 November 2024. <https://www.news-medical.net/news/20100201/Danaher-acquires-AB-SCIEX-and-Molecular-Devices.aspx>.
Chicago
Danaher. "Danaher acquires AB SCIEX and Molecular Devices". News-Medical. https://www.news-medical.net/news/20100201/Danaher-acquires-AB-SCIEX-and-Molecular-Devices.aspx. (accessed November 23, 2024).
Harvard
Danaher. 2019. Danaher acquires AB SCIEX and Molecular Devices. News-Medical, viewed 23 November 2024, https://www.news-medical.net/news/20100201/Danaher-acquires-AB-SCIEX-and-Molecular-Devices.aspx.